Adaptimmune Therapeutics shares owned by DAFNA Capital Management
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by DAFNA Capital Management
from 13F filings
Historical chart of DAFNA Capital Management investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by DAFNA Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $278k | 351k | 0.79 |
| 2023-09-30 | $274k | 351k | 0.78 |
| 2023-06-30 | $325k | 351k | 0.93 |
| 2023-03-31 | $383k | 351k | 1.09 |
| 2022-12-31 | $513k | 351k | 1.46 |
| 2022-09-30 | $377k | 351k | 1.07 |
| 2022-06-30 | $597k | 351k | 1.70 |
| 2022-03-31 | $723k | 351k | 2.06 |
| 2021-12-31 | $511k | 136k | 3.75 |
| 2016-06-30 | $203k | 25k | 8.13 |
| 2016-03-31 | $716k | 88k | 8.13 |
| 2015-12-31 | $580k | 48k | 12.06 |